Potassium Perchlorate

Summary

Potassium Perchlorate (CHEMBL1200696) is an approved small molecule (ATC H03BC01); indicated across 1 condition including thyroid gland disorder.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: H03BC01
• Indications: 1 condition
• Chemistry: 138.55 Da · ClKO4

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1200696
Name	Potassium Perchlorate
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	516900
ATC	H03BC01
Molecular formula	ClKO4
Molecular weight	138.55
InChIKey	YLMGFJXSLBMXHK-UHFFFAOYSA-M

SMILES: [O-]Cl(=O)(=O)=O.[K+]

IUPAC name: potassium perchlorate

Also known as: Perchloracap, Peroidin, Pertiroid, Potassium perchlorate, POTASSIUM PERCHLORATE, SID144212509

Patent coverage: 6,763 distinct patent families (14,514 SureChEMBL compound mentions), from 2 matched compound structure(s). One matched structure accounts for 13,230 (91%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

1 approved indication. FDA phase 4, plus an anticancer drug’s labelled cancer uses (which ChEMBL often logs at phase 3).

Indication	Phase	MONDO	EFO
thyroid gland disorder	4	MONDO:0003240	HP:0000820

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).